September 22, 2008
A new Contact Lens material by 2009?
Analysis of:
Ocutec wins backing for contact lens venture | www.theherald.co.uk
This analysis is solely the work of the author. It has not been edited or endorsed by GLG.
Implications: A new material that is easier to produce contact lenses with may decrease the cost of producing contact lenses. A major difficulty in producing today's silicone hydrogels is production costs.
Analysis: CooperVision's silicone hydrogel contact lenses, Biofinity and Avaira have encountered cost overruns from difficulty producing the product.
Bausch & Lomb's Purevison contact lenses and Novartis's Ciba Vision O2 Optix, Air Optix, and Night & Day materials have run into patent issues in the past year.
A new material that promises easier manufactuering, and has no prior patents with good oxygen transmissability may be an opportunity for a new lens to enter the market.
Analysis: CooperVision's silicone hydrogel contact lenses, Biofinity and Avaira have encountered cost overruns from difficulty producing the product.
Bausch & Lomb's Purevison contact lenses and Novartis's Ciba Vision O2 Optix, Air Optix, and Night & Day materials have run into patent issues in the past year.
A new material that promises easier manufactuering, and has no prior patents with good oxygen transmissability may be an opportunity for a new lens to enter the market.
Report a Concern
More GLG News in
Healthcare
Most Popular:
Source Article | Expert Analyses
Merck KGaA: Overall Survival in First-Line NSCLC Reaches 15 Months
www.pipelinereview.com
Hospitals See Drop in Paying Patients
www.nytimes.com
Painkiller Risk Found for Heart Patients
www.nytimes.com
Gardasil, Merck's Cervical Cancer Vaccine, Demonstrated Efficacy in Preventing HPV-Related Disease in Males in Phase III Study
www.fiercebiotech.com
FDA Asks if Pain Pill Is Tamper-Proof
online.wsj.com
Will contact lens solutions cost more to ship and store?
November 13, 2008
Economy's impact on healthcare facilities
November 13, 2008
Tamper Proof Narcotic Pain pill? YES
November 13, 2008
CVS Escalates the Generic Price War
November 13, 2008
A closer look
November 11, 2008

